Assessing the Value of Reflex Fluorescence In Situ Hybridization Testing in the Diagnosis of Bladder Cancer When Routine Urine Cytological Examination is Equivocal

Journal of Urology

Volumn 179, Issue 4, 2008, Pages 1296-1301

  Kipp, Benjamin R ^a   Halling, Kevin C ^a   Campion, Michael B ^a   Wendel, Amy J ^a   Karnes, R Jeffrey ^a   Zhang, Jun ^a   Sebo, Thomas J ^a  

^a MAYO CLINIC   (United States)

Author keywords

bladder; carcinoma; cytology; fluorescence in situ; hybridization; urothelium

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BLADDER BIOPSY; BLADDER CANCER; CANCER DIAGNOSIS; CANCER SURGERY; CONTROLLED STUDY; CYSTECTOMY; CYSTOSCOPY; CYTODIAGNOSIS; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; URINE CYTOLOGY;

FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 40849135451     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.11.082     Document Type: Article

References (14)

1. Konety B.R. Molecular markers in bladder cancer: a critical appraisal. Urol Oncol 24 (2006) 326
2. Glatz K., Willi N., Glatz D., Barascud A., Grilli B., Herzog M., et al. An international telecytologic quiz on urinary cytology reveals educational deficits and absence of a commonly used classification system. Am J Clin Pathol 126 (2006) 294
3. Nabi G., Greene D., and O'Donnell M.O. Suspicious urinary cytology with negative evaluation for malignancy in the diagnostic investigation of haematuria: how to follow up?. J Clin Pathol 57 (2004) 365
4. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. ASCS-LSIL Triage Study Group. Am J Obstet Gynecol 188 (2003) 1383
5. Skacel M., Fahmy M., Brainard J.A., Pettay J.D., Biscotti C.V., Liou L.S., et al. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol 169 (2003) 2101
6. Skacel M., Pettay J.D., Tsiftsakis E.K., Procop G.W., Biscotti C.V., and Tubbs R.R. Validation of a multicolor interphase fluorescence in situ hybridization assay for detection of transitional cell carcinoma on fresh and archival thin-layer, liquid-based cytology slides. Anal Quant Cytol Histol 23 (2001) 381
7. Sarosdy M.F., Kahn P.R., Ziffer M.D., Love W.R., Barkin J., Abara E.O., et al. Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria. J Urol 176 (2006) 44
8. Halling K.C., King W., Sokolova I.A., Karnes R.J., Meyer R.G., Powell E.L., et al. A comparison of BTA Stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine. J Urol 167 (2002) 2001
9. Bubendorf L., Grilli B., Sauter G., Mihatsch M.J., Gasser T.C., and Dalquen P. Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am J Clin Pathol 116 (2001) 79
10. Kipp B.R., Campion M.B., Coffman E., Smith A., Tomisek J.D., Browne G.G., et al. An evaluation of ThinPrep UroCyte filters for the preparation of slides for fluorescence in situ hybridization. Diagn Cytopathol 34 (2006) 479
11. Yoder B.J., Skacel M., Hedgepeth R., Babineau D., Ulchaker J.C., Liou L.S., et al. Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings. Am J Clin Pathol 127 (2007) 295
12. Kipp B.R., Fritcher E.G., del Rosario K.M., Stevens C.L., Sebo T.J., and Halling K.C. A systematic approach to identifying urothelial cells likely to be polysomic by fluorescence in situ hybridization. Anal Quant Cytol Histol 27 (2005) 317
13. Raab S.S., Grzybicki D.M., Vrbin C.M., and Geisinger K.R. Urine cytology discrepancies: frequency, causes, and outcomes. Am J Clin Pathol 127 (2007) 946
14. Richter J., Jiang F., Gorog J.P., Sartorius G., Egenter C., Gasser T.C., et al. Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res 57 (1997) 2860